Table 2.

Relationships between ALDOB expression and clinicopathological factors in rectal cancer patients receiving preoperative CCRT

Parameter		No.	ALDOB Expression		P-value
			Low Exp.	High Exp.
Gender	Male	108	55	53	0.752
	Female	64	31	33
Age	<70	106	52	54	0.754
	≥70	66	34	32
Pre-CCRT cT stage	cT1-2	81	43	38	0.445
	cT3-4	91	43	48
Pre-CCRT cN stage	cN0	125	72	53	0.001*
	cN1-2	47	14	33
Pre-CCRT CEA	≤5 ng/ml	114	63	51	0.053
	>5 ng/ml	58	23	35
Post-CCRT pT stage	pT0-2	86	53	33	0.002*
	pT3-4	86	33	53
Post-CCRT pN stage	pN0	123	76	47	<0.001*
	pN1-2	49	10	39
Lymphovascular invasion	Absent	157	83	74	0.015*
	Present	15	3	12
Perineural invasion	Absent	167	86	81	0.023*
	Present	5	0	5
Tumor regression grade	Grade 0-1	37	12	25	<0.001*
	Grade 2-3	118	59	59
	Grade 4	17	15	2

*, statistically significant